Reports of liver damage and transplants have surfaced regarding ulipristal acetate (Esmya), now before the FDA for approval to treat uterine fibroids.
News Alerts …read more
Reports of liver damage and transplants have surfaced regarding ulipristal acetate (Esmya), now before the FDA for approval to treat uterine fibroids.
News Alerts …read more